You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ARN-509

Showing 26 - 50 of 77
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Cancer Trial in La Jolla, Boston, New York (Apalutamide, Leuprolide, Prednisone)

Active, not recruiting
Has Results
  • Prostate Cancer
  • La Jolla, California
  • +3 more
Sep 1, 2021

Prostate Cancer Trial in Sao Paulo (Goserelin, Prednisone, Abiraterone)

Unknown status
  • Prostate Cancer
  • Sao Paulo, SP, Brazil
    Instituto do Cancer do Estado de Sao Paulo
May 14, 2021

Prostate Cancer Trial in United States (ARN-509, Abiraterone Acetate, Prednisone)

Active, not recruiting
  • Prostate Cancer
  • ARN-509
  • +2 more
  • New Orleans, Louisiana
  • +13 more
Feb 5, 2022

Prostate Cancer Trial in Worldwide (Apalutamide, Placebo, Androgen Deprivation Therapy (ADT))

Active, not recruiting
Has Results
  • Prostate Cancer
  • Homewood, Alabama
  • +228 more
Aug 2, 2022

Prostate Cancer Trial in France (Apalutamide, Salvage radiotherapy (SRT), Luteinising Hormone Releasing Hormone agonist (LHRHa))

Recruiting
  • Prostate Cancer
  • Albi, France
  • +14 more
Sep 22, 2021

Prostate Cancer Trial in Boston (Leuprolide Acetate, Prednisone, Docetaxel)

Terminated
Has Results
  • Prostate Cancer
  • Leuprolide Acetate
  • +3 more
  • Boston, Massachusetts
  • +1 more
Apr 2, 2020

Cancer of the Prostate Trial in Singapore (Apalutamide)

Completed
  • Cancer of the Prostate
  • Singapore, Singapore
    Department of Urology
Mar 17, 2020

Prostatic Tumors Trial in China (Apalutamide, Placebo, Androgen-deprivation Therapy (ADT))

Recruiting
  • Prostatic Neoplasms
  • Beijing, China
  • +29 more
Aug 15, 2022

Healthy Trial in Merksem (Apalutamide)

Completed
  • Healthy
  • Merksem, Belgium
    Clinical Pharmacology Unit
Aug 7, 2020

Prostatic Tumors Trial in Canada, United States (Niraparib, Apalutamide, Abiraterone Acetate)

Completed
  • Prostatic Neoplasms
  • West Hollywood, California
  • +5 more
Jul 16, 2020

Prostate Cancer Trial in United States (ARN-509, LHRH Agonist)

Completed
Has Results
  • Prostate Cancer
  • ARN-509
  • LHRH Agonist
  • Scottsdale, Arizona
  • +4 more
Feb 27, 2020

Prostate Cancer Trial in Houston (Apalutamide, IHT)

Withdrawn
  • Prostate Cancer
  • Houston, Texas
    UTHealth Memorial Hermann Cancer Center
Feb 25, 2020

Prostate Cancer Trial in Cambridge (Apalutamide)

Completed
  • Prostate Cancer
  • Cambridge, Cambridgeshire, United Kingdom
    Cambridge University Hospitals NHS Foundation Trust/Addenbrookes
Nov 18, 2019

Low Risk Prostate Cancer Trial in France (Apalutamide)

Unknown status
  • Low Risk Prostate Cancer
  • Marseille, Bouches Du Rhône, France
  • +10 more
Sep 25, 2019

PSA Progression, Stage III Prostate Adenocarcinoma, Stage IV Prostate Adenocarcinoma Trial in Canada, United States (drug,

Active, not recruiting
  • PSA Progression
  • +2 more
  • Gilbert, Arizona
  • +362 more
Mar 9, 2022

Prostate Cancer Trial in Brazil (Apalutamide, Abiraterone, ADT)

Completed
  • Prostate Cancer
  • Salvador, Bahia, Brazil
  • +13 more
Jul 5, 2021

Prostate Cancer Trial in Shatin (Apalutamide, Enzalutamide)

Recruiting
  • Prostate Cancer
  • Shatin, Hong Kong
    Prince of Wales Hospital
Aug 3, 2021

Cancer Target Therapy Efficacy

Active, not recruiting
  • Cancer
  • RNA sequencing
  • +5 more
  • Walnut, California
  • +6 more
Sep 13, 2021

Prostate Cancer Trial in Worldwide (AMG 509, Abiraterone, Enzalutamide)

Recruiting
  • Prostate Cancer
  • AMG 509
  • +2 more
  • Duarte, California
  • +18 more
Mar 17, 2022

Lassa Virus Infection Trial in West Bend (ARN-75039 oral capsules, Placebo)

Recruiting
  • Lassa Virus Infection
  • ARN-75039 oral capsules
  • Placebo
  • West Bend, Wisconsin
    Spaulding Clinical, LLC
Feb 16, 2023

Prostate Cancer Trial (Radiation Therapy, Apalutamide, Luteinising Hormone Releasing Hormone analog agonist (LHRHa))

Withdrawn
  • Prostate Cancer
  • Radiation Therapy
  • +3 more
  • (no location specified)
Aug 13, 2020

NSCLC (NSCLC) Trial in Tampa (PBF-509_80 mg, PBF-509_160 mg, PBF-509_320 mg)

Completed
  • Non-small Cell Lung Cancer (NSCLC)
  • PBF-509_80 mg
  • +8 more
  • Tampa, Florida
    H.Lee Moffitt Cancer center
Jan 3, 2022

Childhood Trauma in Schizophrenia: Exploration of Links Between

Recruiting
  • Schizophrenia
  • magnetic resonance imaging (MRI)
  • +2 more
  • Saint-Étienne, France
    CHU de Saint Etienne
Nov 29, 2022

Can Rivaroxaban Lead to Anticoagulation-Related Nephropathy?

Completed
Has Results
  • Acute Kidney Injury
    • Philadelphia, Pennsylvania
      Einstein Medical Center
    Jun 23, 2020

    Cholecystitis Trial (Cefotetan)

    Completed
    • Cholecystitis
    • (no location specified)
    Jan 25, 2021